Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 33% ± 1% | |
glutamatergic neuron | 3 studies | 34% ± 5% | |
astrocyte | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 874.13 | 245 / 245 | 100% | 12.52 | 500 / 502 |
lung | 100% | 815.17 | 576 / 578 | 100% | 10.77 | 1154 / 1155 |
esophagus | 100% | 819.42 | 1445 / 1445 | 99% | 11.16 | 182 / 183 |
breast | 100% | 1132.98 | 459 / 459 | 99% | 14.96 | 1111 / 1118 |
stomach | 100% | 722.39 | 359 / 359 | 99% | 10.65 | 283 / 286 |
pancreas | 100% | 649.50 | 328 / 328 | 99% | 8.39 | 176 / 178 |
brain | 99% | 866.23 | 2608 / 2642 | 100% | 13.68 | 705 / 705 |
intestine | 100% | 843.01 | 966 / 966 | 98% | 9.50 | 519 / 527 |
thymus | 100% | 885.72 | 652 / 653 | 99% | 9.38 | 596 / 605 |
liver | 100% | 868.45 | 226 / 226 | 98% | 8.91 | 398 / 406 |
ovary | 100% | 1398.47 | 180 / 180 | 98% | 7.26 | 421 / 430 |
kidney | 100% | 619.12 | 89 / 89 | 98% | 10.85 | 879 / 901 |
uterus | 100% | 1248.51 | 170 / 170 | 97% | 8.09 | 447 / 459 |
bladder | 100% | 1042.29 | 21 / 21 | 97% | 8.21 | 489 / 504 |
adrenal gland | 100% | 1593.36 | 258 / 258 | 97% | 11.55 | 223 / 230 |
skin | 100% | 1413.49 | 1806 / 1809 | 97% | 16.24 | 457 / 472 |
adipose | 100% | 1164.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1265.69 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 534.12 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.13 | 1 / 1 |
muscle | 100% | 894.52 | 802 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.42 | 44 / 45 |
heart | 94% | 717.06 | 811 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 7.87 | 74 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.86 | 26 / 29 |
peripheral blood | 29% | 338.16 | 271 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0036500 | Biological process | ATF6-mediated unfolded protein response |
GO_0051604 | Biological process | protein maturation |
GO_0031293 | Biological process | membrane protein intracellular domain proteolysis |
GO_0070977 | Biological process | bone maturation |
GO_0045540 | Biological process | regulation of cholesterol biosynthetic process |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_1905897 | Biological process | regulation of response to endoplasmic reticulum stress |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0140537 | Molecular function | transcription regulator activator activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | MBTPS2 |
Protein name | Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease) (SREBPs intramembrane protease) Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P) |
Synonyms | S2P |
Description | FUNCTION: Zinc metalloprotease that mediates intramembrane proteolysis of proteins such as ATF6, ATF6B, SREBF1/SREBP1 and SREBF2/SREBP2 . Catalyzes the second step in the proteolytic activation of the sterol regulatory element-binding proteins (SREBPs) SREBF1/SREBP1 and SREBF2/SREBP2: cleaves SREBPs within the first transmembrane segment, thereby releasing the N-terminal segment with a portion of the transmembrane segment attached . Mature N-terminal SREBP fragments shuttle to the nucleus and activate gene transcription . Also mediates the second step in the proteolytic activation of the cyclic AMP-dependent transcription factor ATF-6 (ATF6 and ATF6B) . Involved in intramembrane proteolysis during bone formation . In astrocytes and osteoblasts, upon DNA damage and ER stress, mediates the second step of the regulated intramembrane proteolytic activation of the transcription factor CREB3L1, leading to the inhibition of cell-cycle progression . . |
Accessions | ENST00000365779.2 B9ZVQ3 O43462 ENST00000379484.10 |